COOKE; John P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for COOKE; John P..The latest application filed is for "mcm for gene therapy to activate wnt pathway".

Company Profile

4.26.31

COOKE; John P. - Houston TX
Cooke; John P. - Stanford CA
Cooke; John P. - Palo Alto CA
Cooke; John P. - Indiatlantic FL
Cooke; John P. - Minneapolis MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mcm For Gene Therapy To Activate Wnt Pathway App 20220273695 - BAHNEY; Chelsea ; et al.	2022-09-01
ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA App 20210130792 - Cooke; John P. ; et al.	2021-05-06
Induction Of Senescence Using Proton Pump Inhibitors App 20200338056 - COOKE; John P. ; et al.	2020-10-29
Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA Grant 10,760,061 - Cooke , et al. Sep	2020-09-01
High resolution imaging using near-infrared-II fluorescence Grant 10,264,974 - Hong , et al.	2019-04-23
Graft for directed vascular and lymphatic regeneration and methods to guide endothelial cell assembly Grant 10,238,769 - Paukshto , et al.	2019-03-26
Telomere Extension And Anti-inflammatory Agents For Cell Regeneration App 20180360924 - NAZARI-SHAFTI; Mir Timo Zadegh ; et al.	2018-12-20
Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA Grant 9,738,873 - Cooke , et al. August 22, 2	2017-08-22
ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA App 20170204376 - Cooke; John P. ; et al.	2017-07-20
High Resolution Imaging Using Near-infrared-ii Fluorescence App 20150297086 - Hong; Guosong ; et al.	2015-10-22
Dimethylarginine Dimethylaminohydrolase Inhibitors and Methods of Use Thereof App 20150238472 - Ghebremariam; Yohannes T. ; et al.	2015-08-27
ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA App 20150225699 - Cooke; John P. ; et al.	2015-08-13
Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof Grant 9,011,882 - Ghebremariam , et al. April 21, 2	2015-04-21
Graft For Directed Vascular And Lymphatic Regeneration And Methods To Guide Endothelial Cell Assembly App 20140242347 - Paukshto; Michael V. ; et al.	2014-08-28
Biomarkers For Predicting Major Adverse Events App 20140187519 - Cooke; John P. ; et al.	2014-07-03
.beta.-2 microglobulin as a biomarker for peripheral artery disease Grant 8,709,735 - Cooke , et al. April 29, 2	2014-04-29
Beta-2 Microglobulin As A Biomarker For Peripheral Artery Disease App 20130260389 - Cooke; John P. ; et al.	2013-10-03
Dimethylarginine Dimethylaminohydrolase Inhibitors and Methods of Use Thereof App 20130224259 - Ghebremariam; Yohannes T. ; et al.	2013-08-29
Activation Of Innate Immunity For Nuclear Reprogramming Of Somatic Cells App 20130202649 - Cooke; John P. ; et al.	2013-08-08
Beta-2 microglobulin as a biomarker for peripheral artery disease Grant 8,377,646 - Cooke , et al. February 19, 2	2013-02-19
Cell-Free Synthesis of Active Reprogramming Transcription Factors App 20120208232 - Yang; William ; et al.	2012-08-16
Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis Grant 8,236,772 - Cooke , et al. August 7, 2	2012-08-07
BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease Grant 8,227,201 - Cooke , et al. July 24, 2	2012-07-24
Biomarkers For Peripheral Artery Disease App 20110313681 - Fung; Eric T. ; et al.	2011-12-22
Biomarkers for peripheral artery disease Grant 8,008,020 - Fung , et al. August 30, 2	2011-08-30
Method and composition for inhibiting cardiovascular cell proliferation App 20100113353 - Cooke; John P. ; et al.	2010-05-06
Beta2-microglobulin And C Reactive Protein (crp) As Biomarkers For Peripheral Artery Disease App 20090042214 - Cooke; John P. ; et al.	2009-02-12
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Grant 7,452,916 - Cooke November 18, 2	2008-11-18
Topical mecamylamine formulations for ocular administration and uses thereof App 20070167526 - Zhang; Xiaoming ; et al.	2007-07-19
Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis App 20070135369 - Cooke; John P. ; et al.	2007-06-14
Method and composition for inhibiting cardiovascular cell proliferation App 20060167402 - Cooke; John P. ; et al.	2006-07-27
Method and composition for inhibiting cardiovascular cell proliferation App 20060159719 - Cooke; John P. ; et al.	2006-07-20
Proteins and methods useful for assessing risk of cardiovascular disease App 20060034819 - Balint; Robert F. ; et al.	2006-02-16
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity App 20060009407 - Cooke; John P. ; et al.	2006-01-12
Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof App 20050202463 - Cooke, John P. ; et al.	2005-09-15
Methods and system for controlling latching exhaust valves Grant 6,896,339 - Moffitt , et al. May 24, 2	2005-05-24
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity App 20040082659 - Cooke, John P. ; et al.	2004-04-29
Method and composition for inhibiting cardiovascular cell proliferation App 20040074504 - Cooke, John P. ; et al.	2004-04-22
Proteins and methods useful for assessing risk of cardiovascular disease App 20030235573 - Balint, Robert F. ; et al.	2003-12-25
Methods and system for controlling latching exhaust valves App 20030218377 - Moffitt, Robert Lyn ; et al.	2003-11-27
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Grant 6,646,006 - Cooke , et al. November 11, 2	2003-11-11
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Grant 6,642,208 - Cooke , et al. November 4, 2	2003-11-04
Method and composition for inhibiting cardiovascular cell proliferation Grant 6,605,115 - Cooke , et al. August 12, 2	2003-08-12
Enhancement Of Vascular Function By Modulation Of Endogenous Nitric Oxide Production Or Activity App 20020151592 - COOKE , John P. ; et al.	2002-10-17
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity App 20020091160 - Cooke, John P. ; et al.	2002-07-11
Assay for asymmetrical NG, NG dimethyl-l-arginine Grant 6,358,699 - Balint , et al. March 19, 2	2002-03-19
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity App 20020013288 - Cooke, John P. ; et al.	2002-01-31
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Grant 6,337,321 - Cooke , et al. January 8, 2	2002-01-08
Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity Grant 6,117,872 - Maxwell , et al. September 12, 2	2000-09-12
Arginine or lysine containing fruit healthbar formulation Grant 6,063,432 - Maxwell , et al. May 16, 2	2000-05-16
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity Grant 5,945,452 - Cooke , et al. August 31, 1	1999-08-31
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Grant 5,891,459 - Cooke , et al. April 6, 1	1999-04-06
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury Grant 5,861,168 - Cooke , et al. January 19, 1	1999-01-19
Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury Grant 5,852,058 - Cooke , et al. December 22, 1	1998-12-22
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity Grant 5,428,070 - Cooke , et al. June 27, 1	1995-06-27
Angleworm storage box Grant 4,210,252 - Cooke , et al. July 1, 1	1980-07-01

Company Registrations

NCAGE Code	3RJN9	COOKE JOHN P
CAGE Code	3RJN9	COOKE, JOHN P

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.